FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Lupin Pharmaceuticals Lisinopril Tablets Recall

Lisinopril Tablets USP, 10 mg, 1000-count bottles, Rx Only, Manufactured for: Lupin Pha…

Lupin Pharmaceuticals Inc. · Baltimore, MD

Risk level
Class II
Reported by FDA
Sep 21, 2022
Recall ID
D-1536-2022
Check your lot numberHow we source this data

Summary

Lupin Pharmaceuticals recalled Lisinopril Tablets starting Sep 13, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1536-2022 on Sep 21, 2022. Reason: Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet. Status: Terminated.

Why it was recalled

Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.

Product description

Lisinopril Tablets USP, 10 mg, 1000-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Nagpur- 441 108, India. NDC 68180-980-03

Lot numbers, UPCs & expiration codes

Lot # Q201182, exp. date March 2024

Where it was sold

Product was distributed to major distributors/wholesalers nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1536-2022
Classification
Class II
Status
Terminated
Recall initiated
Sep 13, 2022
FDA report date
Sep 21, 2022
Quantity
11,802 1000-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Lupin Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-1536-2022, exactly as published.

Show all FDA fields
City
Baltimore
State
MD
Status
Terminated
Country
United States
Event ID
90859
Address
Harborplace Tower
Address (line 2)
111 S Calvert St Fl 21st
Code information
Lot # Q201182, exp. date March 2024
Postal code
21202-6174
Report date
Sep 21, 2022
Product type
Drugs
Recall number
D-1536-2022
Classification
Class II
Recalling firm
Lupin Pharmaceuticals Inc.
Product quantity
11,802 1000-count bottles
Termination date
Jan 31, 2024
Reason for recall
Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lisinopril Tablets USP, 10 mg, 1000-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Nagpur- 441 108, India. NDC 68180-980-03
Distribution pattern
Product was distributed to major distributors/wholesalers nationwide.
Recall initiation date
Sep 13, 2022
Initial firm notification
Letter
Center classification date
Sep 15, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1536-2022, published Sep 21, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls